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http:WHAT THIS PAPER ADDS
Ascending aortic aneurysms develop in response to aortic media remodeling. Upregulation of microRNA-145 has
been reported to be involved in vessel remodeling. In this study the expression of microRNA-145 increased in
the wall of ascending aortic aneurysms. In addition, vascular smooth muscle cells transfected with microRNA-
145 mimics increased their expression of osteopontin and collagen III via the TGF-b1 signaling cascade. These
results indicate that microRNA-145 may play an important role in ascending aortic aneurysm media remodeling.
Downregulation of microRNA-145 could serve as a novel therapeutic approach for ascending aortic aneurysm.Objective: In this study the role of microRNA-145 expression in ascending aortic aneurysm wall media
remodeling was examined.
Methods: Aortic wall samples were obtained from 10 patients who had undergone surgery for ascending aortic
aneurysm. Control aortic tissue samples were obtained from 10 patients who had undergone coronary artery
bypass graft. The levels of microRNA-145 were analyzed using real time quantitative reverse transcriptase
polymerase chain reaction, and western blots were used to determine the expressions of osteopontin (OPN) and
collagen. In vitro cultures of vascular smooth muscle cells (VSMCs) were established from both patient groups.
The VSMCs were transfected with either microRNA-145 mimics or microRNA-145 inhibitors to determine the
effect of microRNA-145 on the expression of OPN and collagen. Furthermore, cells were co-transfected with
microRNA-145 mimics and TGF-b1 siRNA to investigate whether TGF-b1 is involved in the process that microRNA-
145 increases the expression of OPN and collagen.
Results: Aortic microRNA-145, OPN and collagen III was increased in ascending aortic aneurysm patients
compared with controls (p < .05). VSMCs transfected with microRNA-145 mimics increased the expression of
both OPN (average of 1.59-fold, p < .05) and collagen III (mean of 1.71-fold, p < .05). Cells transfected with
microRNA-145 inhibitors decreased expression of both OPN and collagen III compared with negative controls. In
addition, the inhibition of TGF-b1 decreased the positive effect of microRNA-145 on the expression of OPN and
collagen III.
Conclusion: The increased expression of microRNA-145 promotes media remodeling through TGF-b1 in the aortic
aneurysm wall.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Article history: Received 30 July 2014, Accepted 22 October 2014, Available online 25 November 2014
Keywords: Ascending aortic aneurysm, Media remodeling, MicroRNA-145, Osteopontin, Collagen, TGF-b1INTRODUCTION
Ascending aortic aneurysms present a unique pathology
that is related to the anatomical and functional complexity
of the ascending aorta. They increase the risk of aortic
dissection and represent an important source of morbidity
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//dx.doi.org/10.1016/j.ejvs.2014.10.018response to pathological changes that alter the structure
and composition of the aortic extracellular matrix (ECM).2,3
The remodeling leads to an increase in the number of
collagen ﬁbers and in the phenotypic alteration of vascular
smooth muscle cells (VSMCs).1,4,5 Phenotypic alterations
lead to the loss of VSMC’s contractile capacity instead of
proliferative properties.4 Proliferative VSMCs and collagen
ﬁbers that do not possess elasticity, an increased number of
collagen ﬁbers and the VSMC phenotypic alteration in the
aorta may result in decreased arterial distensibility, thereby
increasing the potential for aortic aneurysm.5,6 However,
the mechanisms involved in the remodeling process are not
well understood.
MicroRNAs (miRNAs) are single stranded, non-coding
RNAs that are 22 nucleotides in length and typically
Table 1. Patient characteristics.
Characteristics Ascending aortic
aneurysm patients
Control subjects p
Years (mean  SD) 63.00  6.16 58.40  6.98 .136
Men 7 8 .606
Hypertension 9 8 .531
None of the patients or controls had hereditary disease or family
history of aneurysms.
Overexpression of MicroRNA-145 53function to induce the degradation or translational repres-
sion of speciﬁc target mRNAs.7 A recent study assessed the
direct role of miRNAs in the development of vascular pa-
thologies, for example, miR-155, miR-21, and miR-126 have
been shown to contribute to vascular inﬂammation.8 miR-
145 was shown to be abundantly expressed in the vessel
wall and was considered a marker for the SMC phenotype
and a modulator that is able to control vascular neointimal
lesion formation.9,10 It was shown to regulate the develop-
ment of vascular pathologies through MYOCD (a smooth
muscle-speciﬁc transcriptional coactivator of serum
response factor) or transforming growth factor (TGF)-
b1.11,12 Recently, Caruso and colleagues13 reported that
miR-145 was dysregulated in mouse models of pulmonary
arterial hypertension and the upregulation of miR-145
played an important role in vessel remodeling.
In the present study the expression of miR-145 in
ascending aortic aneurysm tissues was examined and the
hypothesis that miR-145 promotes ascending aortic aneu-
rysm media remodeling was tested.MATERIALS AND METHODS
Materials
Masson’s trichrome staining kit was obtained from Leagene
Biotechnology (Beijing, China). Bicinchoninic acid (BCA)
protein assay kit was purchased from Applygen Technolo-
gies Inc. (Beijing, China). Primary antibodies against osteo-
pontin (catalog no. ab8448), collagen III (catalog no.
ab7778), smooth muscle myosin heavy chain 11 (SM-MHC
11, catalog no. ab133567) and alpha smooth muscle actin
(a-SM actin, catalog no. ab119952) were obtained from
Abcam plc (Cambridge UK) and TGF-b1 (catalog no.
MAB240) was purchased from R&D Systems (Minneapolis,
USA). Primary antibody against GAPDH, FITC-conjugated
goat anti-rabbit IgG, Tex red-conjugated goat anti-mouse
IgG and horseradish peroxidase (HRP)-conjugated second-
ary antibodies were obtained from ZSGB-BIO (Beijing,
China). Dulbecco modiﬁed Eagle medium (DMEM, HyClone)
was purchased from Thermo-Fisher Scientiﬁc (Beijing,
China). Fetal bovine serum (FBS, Gibco) and penicillin-
streptomycin (Gibco) were obtained from Life Technolo-
gies Corporation (New York, USA). miR-145 mimic, miR-145
inhibitor and TGF-b1 siRNA were purchased from Shanghai
GenePharma Co., Ltd (Shanghai, China).Patient enrollment and tissue collection
Before the operation, written informed consent was ob-
tained from patients, in accordance with the declaration of
Helsinki and after obtaining approval from the Fuwai Car-
diovascular Hospital’s Institutional Review Board. Clinical
data and aortic specimens were obtained from 10 consecu-
tive patients undergoing elective surgery for ascending aortic
aneurysm associated with the tricuspid aortic valve and from
10 control patients with non-aneurysmal aortas undergoing
coronary artery bypass graft. No patients with bicuspid aortic
valves or hereditary connective tissue disorders wereincluded. Full thickness aortic specimens were formalin ﬁxed
or frozen and stored in liquid nitrogen until analysis. The
patients’ characteristics are summarized in Table 1.
Histopathology
Segments from the aortic specimens ﬁxed in formalin were
embedded in parafﬁn and cut into 3 mm slices. Hematoxylin
and eosin (H&E) staining was used to assess aortic wall
morphology. Masson’s trichrome stain was used to evaluate
collagen in the aortic wall. Stained aortic specimens were
imaged under a ﬂuorescent microscope (Leica, Germany).
Western blot analysis
Aortic tissues or cells were homogenized in RIPA lysis buffer
(Roche, Basel, Switzerland). Protein concentration was
quantiﬁed by BCA protein assays. Equal amounts of protein
extracts (20 mg/lane) were loaded on a 10% SDSePAGE gel
and subsequently transferred onto a polyvinylidene ﬂuoride
membrane (Milipore, MA, USA). Membranes were blocked
with 5% bovine serum albumin for 2 hours and then incu-
bated overnight with primary rabbit antibodies against OPN
(1:1000), collagen III (1:500), or TGF-b1 (1 mg/ml). The
secondary antibody conjugated with horseradish peroxidase
was then used for primary antibody detection. The bands
were detected by means of enhanced chemiluminescence
(Milipore, Massachusetts, USA). Anti-rabbit-GADPH anti-
body (1:1000) was used as a housekeeping control.
RNA extraction and real time quantitative reverse
transcriptase polymerase chain reaction (qRT-PCR) analysis
Total RNAwas extracted from both the aortic tissues and cells
using Trizol (Roche, Basel, Switzerland), according to the
manufacturer’s protocol. First strand cDNA synthesis was
performed for each RNA sample using the Superscript II RT Kit
(Applied Biosystems, New York, USA). Real time quantitative
polymerase chain reaction was performed using Taqman PCR
reagents (Applied Biosystems), and the primers for miR-145
were designed according to the manufacturer’s recommen-
dations (hsa-miR-145-5p: GUCCAGUUUUCCCAGGAAUCCCU).
The relative amount of miRNA was standardized against U6
snRNA,14 and the fold change for miRNA-145 was calculated
using the 2-DD computed tomography method.
Primary culture of aortic VSMCs and immunoﬂuorescence
staining
Aortic tissues obtained from both patients with ascending
aortic aneurysms and control subjects were used to
establish VSMC cultures. The samples were placed in sterile
54 H. Pei et al.50 ml centrifuge tubes ﬁlled with phosphate buffered saline
(PBS) in the operating room and immediately transported to
the laboratory. Under sterile conditions, the aortic tissue
was rinsed 3 times with PBS, and the intima and adventitia
were carefully removed with hemostats. The media layer
was cut into 2  2 mm pieces and placed in a 25 ml culture
ﬂask. Three milliliters of complete medium (DMEM, 15%
FBS and 1% penicillin-streptomycin) were added to the
culture ﬂask. The medium was changed every other day.
Approximately 14 days were required to obtain primary
VSMCs. Immunoﬂuorescence staining was used to identify
VSMCs with either anti-a-SM actin monoclonal antibody
(1:800) or anti-SM-MHC 11 (1:400) monoclonal antibody.
IgG with either FITC or Texas Red served as the secondary
antibody, and 4, 6-diamidino-2-phenylindole (DAPI) was
used for nuclear staining.
Transfection
The miR-145 mimic, miR-145 inhibitor and TGF-b1 siRNA
were chemically synthesized by GenePharm (Shanghai,
China). The sequence for the miR-145 mimic was 50-GUC-
CAGUUUUCCCAGGAAUCCCU-30. The sequence for the miR-
145 inhibitor was 50-AGGGAUUCCUGGGAAAACUGGAC-30.
The sequences for the double strands of siRNA for TGF-b1
were 50-GACACCAACUAUUGCUUCATT-30 (sense), and 30-
UGAAGCAAUAGUUGGUGUCTT-50 (antisense).
Transfection of miR-145 mimics, the miR-145 inhibitor
(600 pmol/5 ml medium) and TGF-b1 siRNA into cells was
achieved using the Lipofectamine 2000 reagent (Invitrogen)
according to the manufacturer’s protocol.
Statistical analyses
Continuous variables are reported as the mean  standard
deviation (SD) or median with the interquartile range.Figure 1. Histological appearance of the ascending aortic wall. Aortic tis
their shape and typical lamellar organization in ascending aortic ane
staining shows increased deposition of collagen (blue) in aortic aneuryStatistical analysis was performed using the Student t test
to compare the two groups from Western blotting tests.
Owing to the small sample size and often abnormally
distributed data, we used the ManneWhitney U test to
examine the statistical signiﬁcance of the expression of
miRNA-145 and osteopontin between two groups. The
relationship between two variables was analyzed by corre-
lation coefﬁcients and linear regression analysis. A p value
<.05 was considered statistically signiﬁcant.
RESULTS
Histopathological analysis of ascending aortic wall
H&E staining revealed that the VSMCs lost their typical
lamellar organization. Furthermore, the orientation was
random in the ascending aortic aneurysm tissue, in com-
parison with the spindle-shaped VSMCs in control tissues
(Fig. 1A,B). Masson’s trichrome staining showed increased
deposition of collagen in ascending aortic aneurysm media
compared with the controls (Fig. 1C,D).
VSMC cultures were established from each aortic sample.
Immunoﬂuorescence staining showed that cultured VSMCs
displayed positive staining with anti-a-SM actin antibody
and anti-SM-MHC antibody, conﬁrming that the cells were
VSMCs (Supplementary Fig. 1).The level of osteopontin and collagen is increased in the
aortic wall of ascending aortic aneurysm
The proliferative VSMC phenotype is characterized by an
enhanced secretion of OPN.15,16 The amount of OPN in the
aortic media was examined to determine the expression of
proliferative VSMC phenotypes. As shown in (Fig. 2A), the
aortic tissues of aneurysmal patients had more OPN than
the non-aneurysmal patients (control) (p < .0001). Collagensues stained with H&E show that vascular smooth muscle cells lose
urysm wall (B) compared with controls (A). Masson’s trichrome
sm tissues (D) compared with controls (C).
Figure 2. Western blot assay of the expressions of osteopontin (OPN) and collagen III in patients with aortic aneurysm and controls.
Compared with controls, the expression of OPN (A) and collagen III (B) increased in the ascending aortic aneurysm wall. Results shown
represent mean  SD or median with the interquartile range of 10 samples. ***p < .0001 by ManneWhitney U test, *p ¼ 0.001 by the
Student t test.
Overexpression of MicroRNA-145 55III was the main component of the collagen ﬁbers in the
aortic wall,17 with the expression of collagen III conﬁrmed
by western blot, which was signiﬁcantly increased in
ascending aortic aneurysm tissues compared with controls
(p ¼ .001) (Fig. 2B). The results suggest that signiﬁcant
media remodeling occurred in aortic wall of the ascending
aortic aneurysm samples.The expression of miR-145 is increased in ascending aortic
aneurysm
Because previous studies have reported that miR-145 is
related to vessel remodeling, qRT-PCR was performed to
detect the miR-145 levels in both aortic aneurysm and
control tissues. Compared with the control, the expression
of miR-145 was signiﬁcantly increased in the wall of an
ascending aortic aneurysm (p ¼ .021) (Fig. 3A). In addition,
the expression of miR-145 was positively correlated to the
level of OPN (r ¼ .549, p ¼ .012), the amount of collagen III
(r ¼ 0.547, p ¼ .012) and the aortic diameter (r ¼ 0.547,
p ¼ .012) (Fig. 3BeD).miR-145 regulates the expression of OPN and collagen III
Given the positive correlation between the miR-145 level
and the OPN and collagen III expression levels, the direct
effects of miR-145 on the expression of both OPN and
collagen III was assessed next. VSMCs from control subjects
were transfected with miR-145 mimics. miR-145 levels were
determined by RT-PCR and on average an increase of 7.4-
fold was found in successful transfections. Compared with
the cells transfected with the negative control, VSMCs from
control subjects transfected with miR-145 mimics displayed
an increase in the expression of both OPN (average of 1.59-
fold, p ¼ .022) and collagen III (average of 1.71-fold,
p ¼ .047) (Fig. 4A,B). In addition, VSMCs from ascending
aortic aneurysm samples that were transfected with miR-
145 inhibitor displayed decreased expression levels of
both OPN and collagen III compared with the negativecontrols (p ¼ .031 and p ¼ .041, respectively) (Fig. 5). miR-
145 levels were determined by RT-PCR and on average a
twofold decrease was found in successful transfections.miR-145 regulates the expression of OPN and collagen III
via TGF-b1 signaling cascade
To elucidate the mechanism by which miR-145 modulates
the expression of OPN and collagen III, the effect of miR-145
on the TGF-b cascade was assessed. Compared with the
cells transfected with the negative control, VSMCs from
control subjects transfected with miR-145 mimics displayed
an increase in the expression of TGF-b1 (average of 2.1-fold,
p ¼ .020) (Fig. 4C).
To determine whether miR-145 increased the expression
of OPN and collagen III in a TGF-b-dependent manner,
VSMCs from control subjects were treated with TGF-b1
siRNA, and miR-145 mimics were transfected 6 hours later.
A successful TGF-b1 siRNA transfection was conﬁrmed using
green ﬂuorescent protein expressing negative controls. As
expected, the inhibition of TGF-b1 combined with miR-145
mimics led to a decrease in the expression of OPN and
collagen III compared with cells that were transfected with
negative control and miR-145 mimics (p ¼ .013 and
p ¼ .018, respectively) (Fig. 6).DISCUSSION
Ascending aortic aneurysm is associated with many disor-
ders and syndromes. The primary causes have previously
been classiﬁed as hereditary, congenital, degenerative, in-
ﬂammatory, and infectious.18 However, it appears that in
the majority of patients, the aneurysm cannot be related to
any speciﬁc etiology and is therefore classiﬁed as an idio-
pathic ascending aortic aneurysm. All patients included in
this study had idiopathic ascending aortic aneurysm.
Histological examinations of the ascending aortic aneu-
rysm samples showed signs of media remodeling, including
VSMC disarray and collagen deposition. VSMCs are
Figure 3. The expression of miR-145 in aortic tissues and the relationship between miR-145 expression and the level of osteopontin (OPN)
and collagen III, and aortic diameter. The level of miR-145 increased in the aortic aneurysm wall compared with control (A), and the
expression of miR-145 was positively correlated with the level of OPN (B), the amount of collagen III (C) and the aortic diameter (D).
Results shown represent median with the interquartile range of 10 samples. The relationship between two variables was analyzed by
correlation coefﬁcients and linear regression analysis. *p ¼ 0.021 by ManneWhitney U test.
56 H. Pei et al.considered key structural components of the aorta that
possess both contractile and secretory properties and are
able to alternate between the contractile and proliferative
states.19 In response to vascular injury, the VSMCs increase
their rate of cell proliferation and their ability to synthesize
ECM, thus playing an important role in vascular repair.5
However, changes in the VSMC phenotype may be accom-
panied by disordered VSMC orientation.20 Parrish and col-
leagues reported that the differential processing of OPN
characterizes the proliferative VSMC phenotype. In this
study, OPN was detected with western blot and was
increased in the aortic wall of patients with aortic aneurysm
compared with the controls. This ﬁnding suggests that the
manner of proliferative VSMCs was increased in the aortic
aneurysm wall.
Type III collagen was found to be one of the most
abundant collagen ﬁbers in the aortic wall,17 and it provides
tensile strength and contributes to the overall rigidity of the
aorta.1 The collagen content of the aortic wall has been
extensively studied and has shown conﬂicting results. Some
reports show a decreased expression of collagen in
ascending aortic aneurysm wall,21,22 whereas others show
increased amounts.6,23 It appears that either increases or
decreases in collagen may weaken the aortic wall. In thisstudy, the amount of collagen III increased in the wall of the
ascending aortic aneurysm. Increased collagen may be
compensating for the loss of both the elastic matrix and
VSMCs to prevent progressive aortic aneurysm growth.
However, an over-accumulation of collagen in the aorta may
lead to medial ﬁbrosis, which could result in decreased
arterial compliance and increased progression of the aortic
aneurysm.6
The mechanisms driving the media remodeling are poorly
understood. miR-145 is the most abundant miRNA in
vascular walls and in isolated VSMCs, and miR-145 is a
VSMC phenotypic marker that mediates the phenotypic
modulation through its downstream molecules.9 Recently,
Lovren and colleagues24 reported that a SMC-targeted miR-
145 treatment markedly increased collagen content in
atherosclerotic plaque. This current study showed increased
amounts of miR-145 in the ascending aortic aneurysm tis-
sue. In addition, the expression of miR-145 was positively
correlated with the level of OPN and the amount of collagen
III. Furthermore, normal VSMCs treated with miR-145
mimics increased their expression of OPN and collagen III,
while VSMCs from the ascending aortic aneurysm samples
transfected with miR-145 inhibitor decreased their levels of
OPN and collagen III. Collectively, these observations
Figure 4. The effect of miR-145 mimics on the expression of osteopontin (OPN), collagen III, and transforming growth factor (TGF)-b1.
Vascular smooth muscle cells (VSMCs) from controls transfected with miR-145 mimics display an increase in the expression of OPN (A),
collagen III (B) and TGF-b1 (C). Mimic, miR-145 mimic; NC, negative control. Results shown represent mean  SD of three samples.
*p ¼ 0.022 (A), 0.047 (B) and 0.020 (C) by the Student t test.
Overexpression of MicroRNA-145 57suggest that the over-expression of miR-145 may promote
media remodeling in the aortic wall of an ascending aortic
aneurysm.
TGF-b is a soluble peptide growth factor that has been
implicated in a number of divergent cellular processes.25Figure 5. The effect of inhibition of miR-145 on the expression of osteop
from aneurysm samples transfected with miR-145 inhibitor display a d
miRNA-145 inhibitor; NC, negative control. Results shown represent m
Student t test.Many studies examining the biological effects of TGF-b on
cells have demonstrated that TGF-b treatment could stimu-
late collagen production and deposition.26 In addition, TGF-b
has been shown to play an important role in regulating SMC
proliferation, migration, and apoptosis.27 miR-145 has beenontin (OPN) and collagen III. Vascular smooth muscle cells (VSMCs)
ecrease in the expression of OPN (A) and collagen III (B). Inhibitor,
ean  SD of three samples. *p ¼ 0.031 (A) and 0.041 (B) by the
Figure 6. miRNA-145 regulated the expression of osteopontin (OPN) and collagen III through transforming growth factor (TGF)-b1. Vascular
smooth muscle cells (VSMCs) from controls were treated with miRNA-145 mimics after TGF-b1 siRNA was transfected 6 hours later
(Mimic þ TGF-b1 siRNA). The results show that the inhibition of TGF-b1 decreases the positive effect of miRNA-145 mimics on the
expression of OPN (B) and collagen III (C) compared with cells that were transfected with negative control (NC) and miRNA-145 mimics
(Mimic þ NC). (A) The ratio of OPN and collagen III expressed in Mimic þ TGF-b1 siRNA group to that of Mimic þ NC group. Results shown
represent mean  SD of three samples. *p ¼ 0.013 (A) and 0.018 (B) by the Student t test.
58 H. Pei et al.shown to be one of the TGF-b1 pathway related miRs.28 miR-
145 may promote media remodeling via the TGF-b cascade.
In this study, it has been conﬁrmed that over-expression of
miR-145 increased the level of TGF-b1 and that the inhibition
of the TGF-b1 cascade decreased the positive effect of miR-
145 on the expression of OPN and collagen III. It is well
known that miRNAs repress their target gene expression.
TGF-b2 and TGF-b type II receptor (TGFbR2) were found to
be target genes of miR-145 based on an in silico analyses
(version 5.1, http://www.targetscan.org/), overexpression of
miR-145 decreased the level of TGF-b2 and TGF-bR2, and
then reduced the function of TGF-b. Over-expression of TGF-
b1 may compensate for the loss of TGF-b2 and TGF-bR2.
The phenotypic transformation of VSMCs and collagen
deposition may play an important role in vascular repair in
the early stages. Such changes may explain the low pro-
pensity of small ascending aortic aneurysms to rupture.
However, proliferative VSMCs and collagen ﬁbers do not
possess the elasticity required to prevent plastic deforma-
tion.29 Hence, the phenotypic transformation of VSMCs and
collagen deposition can contribute to the progression of
vascular disease. In addition, our study showed that the
expression of miR-145 was positively related to the aortic
diameter.CONCLUSION
The results of the present study show that over-expression
of miR-145 promotes media remodeling through TGF-b1 in
the ascending aortic aneurysm wall. These changes mayhelp to decrease the rate of small ascending aortic aneu-
rysm ruptures. However, decreased elasticity would result
in the progression of the ascending aortic aneurysm. For
this reason, the study highlights the potential for miR-145
downregulation as a novel therapeutic approach for
ascending aortic aneurysm.
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